↓ Skip to main content

CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients

Overview of attention for article published in BMC Cancer, June 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients
Published in
BMC Cancer, June 2010
DOI 10.1186/1471-2407-10-247
Pubmed ID
Authors

Dimo Dietrich, Manuel Krispin, Jörn Dietrich, Anne Fassbender, Jörn Lewin, Nadia Harbeck, Manfred Schmitt, Serenella Eppenberger-Castori, Vincent Vuaroqueaux, Frédérique Spyratos, John A Foekens, Ralf Lesche, John WM Martens

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 29%
Researcher 8 15%
Student > Master 7 13%
Professor 4 8%
Professor > Associate Professor 3 6%
Other 9 17%
Unknown 6 12%
Readers by discipline Count As %
Agricultural and Biological Sciences 19 37%
Biochemistry, Genetics and Molecular Biology 9 17%
Medicine and Dentistry 7 13%
Chemistry 5 10%
Mathematics 2 4%
Other 3 6%
Unknown 7 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2012.
All research outputs
#7,551,483
of 23,036,991 outputs
Outputs from BMC Cancer
#2,097
of 8,365 outputs
Outputs of similar age
#34,358
of 96,705 outputs
Outputs of similar age from BMC Cancer
#26
of 68 outputs
Altmetric has tracked 23,036,991 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,365 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,705 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.